Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Conditions

• Small Cell Lung Cancer Metastatic or Locally Advanced
• Neuroendocrine Cancer
• Metastatic or Locally Advanced Neuroendocrine Prostate Cancer
• Metastatic or Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
• Metastatic or Locally Advanced Merkel Cell Carcinoma
• Locally Advanced or Metastatic Large Cell Neuroendocrine Carcinoma of the Lung
• Metastatic or Locally Advanced Extrapulmonary Neuroendocrine Carcinoma
• Poorly Differentiated and/or High Grade Neuroendocrine Neoplasms With Evidence of DLL3 Expression

Interventions

• DRUG: BL-M14D1

Sponsor

SystImmune Inc.